Join
Live feed
·
INSIDERFilingvia Quantisnow
Neurocrine Biosciences Inc. logo

Chief Regulatory Officer Delaet Ingrid covered exercise/tax liability with 13,126 shares, was granted 19,935 shares and converted options into 4,360 shares, increasing direct ownership by 221% to 16,225 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBIX (Neurocrine Biosciences Inc.) and more on Quantisnow.